Inflammatory bowel diseases: An immunological approach Enfermedad inflamatoria intestinal: Una mirada inmunológica
Author
dc.contributor.author
Sepúlveda, Sofía E.
Author
dc.contributor.author
Beltrán, Caroll J.
Author
dc.contributor.author
Peralta, Alexis
Author
dc.contributor.author
Rivas, Paola
Author
dc.contributor.author
Rojas, Néstor
Author
dc.contributor.author
Figueroa, Carolina
Author
dc.contributor.author
Quera Pino, Rodrigo
Author
dc.contributor.author
Hermoso Ramello, Marcela
Admission date
dc.date.accessioned
2019-03-11T12:55:52Z
Available date
dc.date.available
2019-03-11T12:55:52Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 136, Issue 3, 2018, Pages 367-375
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164539
Abstract
dc.description.abstract
Inflammatory bowel diseases (IBD) are inflammatory diseases with a multifactorial component that involve the intestinal tract. The two relevant IBD syndromes are Crohn's disease (CD) and ulcerative colitis (UC). One factor involved in IBD development is a genetic predisposition, associated to NOD2/CARD15 and Toll-like receptor 4 (TLR4) polymorphisms that might favor infectious enterocolitis that is possibly associated to the development of IBD. The identification of specific immunologic alterations in IBD and their relationship to the etiology of the disease is a relevant research topic. The role of intra and extracellular molecules, such as transcription factors and cytokines that are involved in the inflammatory response, needs to be understood. The relevance of immunologic molecules that might drive the immune response to a T helper (Th) 1, Th 2 or the recently described Th 17 phenotype, has been demonstrated in animal models and clinical studies with IBD patients. CD and UC predomi